Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Novartis names Mukul Mehta as CFO

Ruchika Sharma17 July 2025 12:46 PM IST

Basel: Novartis has announced the appointment of Mukul Mehta as the Chief Financial Officer (CFO) and a member of the Executive Committee of...

Sanofi India names Rachid Ayari as Interim MD

Sanofi India appoints Rachid Ayari as Interim MD

Ruchika Sharma17 July 2025 12:05 PM IST

Mumbai: Sanofi India has appointed Rachid Ayari as its Interim Managing Director, while continuing in his current role as Chief Financial Officer...

USFDA warns pharma cos to remove misleading ads

Zydus Matoda facility completes USFDA Remote Regulatory Assessment

Ruchika Sharma17 July 2025 11:24 AM IST

Ahmedabad: Zydus Lifesciences has announced that the U.S. Food and Drug Administration (USFDA) has conducted a Remote Regulatory Assessment (RRA)...

India Cuts API Imports, Disburses Rs 1,008 Cr Under PLI Schemes, Parliament Told

20 lakh tablets seized in biggest pharma drug haul in Lucknow

Ruchika Sharma17 July 2025 10:30 AM IST

Lucknow: The Central Bureau of Narcotics (CBN), Lucknow Zone, has recovered nearly 20 lakh tablets of controlled medicines and 5,700 bottles...

Lupin rolls out Loteprednol Etabonate Ophthalmic Suspension in US

Lupin rolls out Loteprednol Etabonate Ophthalmic Suspension, 0.5% in US

Ruchika Sharma16 July 2025 5:04 PM IST

Mumbai: Global pharma major Lupin Limited has launched Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States,...

GSK blood cancer drug Blenrep faces USFDA scrutiny over vision issues

Ruchika Sharma16 July 2025 4:15 PM IST

GSK's blood cancer drug, Blenrep, is under the U.S. Food and Drug Administration (USFDA) spotlight, as staff reviewers raised safety concerns on...

First patient randomized in Ropanicant Phase 2b trial for Major Depressive Disorder: Suven Life Sciences

Ruchika Sharma16 July 2025 2:47 PM IST

Hyderabad: Suven Life Sciences has announced that the first patient has been randomized in its Phase-2b clinical trial evaluating Ropanicant, a...

Sanofi Wayrilz wins USFDA approval for adults with immune thrombocytopenia

Sanofi intravitreal gene therapy wins USFDA fast track designation for geographic atrophy due to age-related macular degeneration

Ruchika Sharma16 July 2025 1:30 PM IST

Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time intravitreal gene therapy...

Shilpa Medicare Dabaspet unit gets VAI classification from USFDA

Ruchika Sharma16 July 2025 12:14 PM IST

Karnataka: Shilpa Medicare Limited has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI)...

Biocon inaugurates first US manufacturing facility in New Jersey

Biocon Biologics expands biosimilar insulin portfolio with USFDA nod of Kirsty

Ruchika Sharma16 July 2025 11:30 AM IST

Karnataka: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has received approval...

Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license

Boehringer Ingelheim, LEO Pharma collaborate to commercialize, further develop Spevigo

Ruchika Sharma16 July 2025 10:30 AM IST

Boehringer Ingelheim set to receive EUR 90 million as upfront payment, along with milestone payments and tiered royalties.

Aurobindo Pharmas subsidiary CuraTeQ Biologics Secures MHRA Approval for Trastuzumab Biosimilar Dazublys in HER2-Positive Cancer

Aurobindo Pharma to manufacture, supply HIV treatment cabotegravir across 133 countries

Ruchika Sharma15 July 2025 5:46 PM IST

New Delhi: Hyderabad-based drugmaker Aurobindo Pharma will produce and supply Cabotegravir, a long-acting injectable HIV treatment, across 133...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok